-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Outperform on CVS Health, Raises Price Target to $94

Benzinga·04/15/2026 10:58:59
Listen to the news
Baird analyst Michael Ha maintains CVS Health (NYSE:CVS) with a Outperform and raises the price target from $92 to $94.